AML-3

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Methods to impair hematologic cancer progenitor cells and compounds related thereto
US 7651678 B2Applicant: UNIV KENTUCKY RES FOUNDPriority: 2001
US
8 publications
Method for treatment of blood tumor using anti-TIM-3 antibody
US 8647623 B2Applicant: TAKAYANAGI SHINICHIROPriority: 2009
US
6 publications
COMPOSITIONS COMPRISING A DHODH INHIBITOR FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA
EP 4048251 A1Applicant: RHIZEN PHARMACEUTICALS AGPriority: 2019
CN
EP
US
WO
4 publications
CD70 combination therapy
US 11530271 B2Applicant: ARGENX BVPriority: 2018
CN
EP
US
4 publications
Antibodies specific for FLT3 and their uses
US 11421040 B2Applicant: PFIZERPriority: 2017
CN
US
4 publications
DOSAGE REGIMEN FOR SAPACITABINE AND DECITABINE IN COMBINATION FOR TREATING ACUTE MYELOID LEUKEMIA
EP 3560501 A1Applicant: CYCLACEL LTDPriority: 2011
EP
US
3 publications
Nitrogen-containing heterocyclic compound or salt thereof
US 9145415 B2Applicant: FUJIFILM CORPPriority: 2012
CN
US
3 publications
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof
US 11203601 B2Applicant: BROAD INST INCPriority: 2017
CN
US
3 publications
Human monoclonal antibodies specific for FLT3 and uses thereof
US 11236171 B2Applicant: US HEALTHPriority: 2017
EP
US
3 publications
Targeting Pleckstrin-2 for treating cancer
US 12629424 B2Applicant: UNIV NORTHWESTERNPriority: 2018
US
WO
3 publications